Moolec Science Statistics
Total Valuation
Moolec Science has a market cap or net worth of $29.98 million. The enterprise value is $48.46 million.
Important Dates
The next estimated earnings date is Wednesday, March 12, 2025, before market open.
| Earnings Date | Mar 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Moolec Science has 38.44 million shares outstanding. The number of shares has increased by 5.31% in one year.
| Current Share Class | 38.44M |
| Shares Outstanding | 38.44M |
| Shares Change (YoY) | +5.31% |
| Shares Change (QoQ) | +6.80% |
| Owned by Insiders (%) | 14.17% |
| Owned by Institutions (%) | 0.20% |
| Float | 5.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.46 |
| Forward PS | 4.43 |
| PB Ratio | 5.27 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.51, with a Debt / Equity ratio of 3.88.
| Current Ratio | 1.51 |
| Quick Ratio | 0.71 |
| Debt / Equity | 3.88 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.49 |
Financial Efficiency
Return on equity (ROE) is -104.72% and return on invested capital (ROIC) is -28.14%.
| Return on Equity (ROE) | -104.72% |
| Return on Assets (ROA) | -20.16% |
| Return on Invested Capital (ROIC) | -28.14% |
| Return on Capital Employed (ROCE) | -35.23% |
| Revenue Per Employee | $104,655 |
| Profits Per Employee | -$146,861 |
| Employee Count | 52 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 1.73 |
Taxes
| Income Tax | -859,683 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.40% in the last 52 weeks. The beta is -0.48, so Moolec Science's price volatility has been lower than the market average.
| Beta (5Y) | -0.48 |
| 52-Week Price Change | -58.40% |
| 50-Day Moving Average | 0.79 |
| 200-Day Moving Average | 0.93 |
| Relative Strength Index (RSI) | 56.10 |
| Average Volume (20 Days) | 13,826 |
Short Selling Information
The latest short interest is 127,266, so 0.33% of the outstanding shares have been sold short.
| Short Interest | 127,266 |
| Short Previous Month | 129,301 |
| Short % of Shares Out | 0.33% |
| Short % of Float | 2.37% |
| Short Ratio (days to cover) | 12.12 |
Income Statement
In the last 12 months, Moolec Science had revenue of $5.44 million and -$7.64 million in losses. Loss per share was -$0.20.
| Revenue | 5.44M |
| Gross Profit | 266,946 |
| Operating Income | -8.88M |
| Pretax Income | -8.08M |
| Net Income | -7.64M |
| EBITDA | -7.88M |
| EBIT | -8.88M |
| Loss Per Share | -$0.20 |
Full Income StatementBalance Sheet
The company has $3.61 million in cash and $22.08 million in debt, giving a net cash position of -$18.47 million or -$0.48 per share.
| Cash & Cash Equivalents | 3.61M |
| Total Debt | 22.08M |
| Net Cash | -18.47M |
| Net Cash Per Share | -$0.48 |
| Equity (Book Value) | 5.69M |
| Book Value Per Share | 0.15 |
| Working Capital | 3.79M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.71 million and capital expenditures -$113,580, giving a free cash flow of -$8.82 million.
| Operating Cash Flow | -8.71M |
| Capital Expenditures | -113,580 |
| Free Cash Flow | -8.82M |
| FCF Per Share | -$0.23 |
Full Cash Flow StatementMargins
Gross margin is 4.91%, with operating and profit margins of -163.11% and -140.33%.
| Gross Margin | 4.91% |
| Operating Margin | -163.11% |
| Pretax Margin | -156.12% |
| Profit Margin | -140.33% |
| EBITDA Margin | -144.88% |
| EBIT Margin | -163.11% |
| FCF Margin | n/a |